Saeed Hesaraki

Dr. Saeed Hesaraki

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Journal of Veterinary Research
Verified
Journal Article
Open access
PDF file
HEHadi Eftekhari
Hadi Eftekhari
AJAlireza Jahandideh
Alireza Jahandideh
AAAhmad Asghari
Ahmad Asghari
AAAbolfazl Akbarzadeh
Abolfazl Akbarzadeh
SHSaeed Hesaraki
Saeed Hesaraki
Introduction: In recent years, the use of bone scaffolds as bone tissue substitutes, especially the use of such as hydroxyapatite and tricalcium phosphate, has been very popular. Today, the use of modern engineering techniques and advances in nanotechnology have expanded the use of nanomaterials as bone scaffolds for bone tissue applications. Material and Methods: This study was performed on 60 adult male New Zealand rabbits divided into four experimental groups: the control group without any treatment, the second group receiving hydroxyapatite, the third group treated with β-tricalcium phosphate, and the fourth group receiving nanocomposite polycaprolactone (PCL) scaffold. In a surgical procedure, a defect 6 mm in diameter was made in a hind limb femur. Four indexes were used to assess histopathology, which were union index, spongiosa index, cortex index, and bone marrow. Results: The results showed that nanocomposite PCL and control groups always had the respective highest and lowest values among all the groups at all time intervals. The histopathological assessment demonstrated that the quantity of newly formed lamellar bone in the nanocomposite PCL group was higher than in other groups. Conclusion: All these data suggest that PCL had positive effects on the bone healing process, which could have great potential in tissue engineering and clinical applications.

20 October 2022 in International Journal of Cancer Management
Verified
Journal Article
Open access
PDF file
ALAmirhosain Lotfi
Amirhosain Lotfi
SRSiamak Mashhady Rafie
Siamak Mashhady Rafie
SHSaeed Hesaraki
Saeed Hesaraki
KAKumarss Amini
Kumarss Amini
Background: Doxorubicin is a favorite drug for feasting many malignancies. All organs' hepatic toxic effects are destructive and lead to use with caution. Then, it is necessary to increase antioxidants accompanied with doxorubicin to reduce its toxicity. Vitamin E is an antioxidant with harmful consequences. Omega-3 is an antioxidant similarly. The healing capacity of Vitamin E- Omega-3 was investigated together against doxorubicin. Methods: Thirty balb/c mice have divided a weight of 25 g into five equal groups of six mice each. The groups were classified as Control: Normal saline; DOX: Doxorubicin; Vitamin E: Vitamin E + DOX; Omega-3; Omega-3 + DOX; Both Vitamin E- Omega-3 + DOX. The histopathology was set to describe vacuolar degeneration, inflammation, and necrosis. Immunohistochemistry was performed to estimate the expression of tumor necrosis factor (TNFα), demonstrating the inflammation. Results: DOX-induced hepatic injury and increased TNF-α expression were seen more than alone when co-administered with vitamin E and omega-3. A significant decrease was shown in the ALT, AST, GGT, and ALP levels compared to the control. The Glutathione peroxidase and Catalase enzyme activities were higher in the co-administered Vitamin E- Omega-3 group than that received Vit E or Omega-3. Conclusions: Co-administration of Vitamin E and Omega-3 have a more repair capacity with controlling effects on Doxorubicin-induced liver toxicity.

1 March 2017 in Iranian Journal of Toxicology
Verified
Journal Article
Open access
PDF file
OKOmid Karimi
Omid Karimi
SHSaeed Hesaraki
Saeed Hesaraki
SMSeyyed Pejman Mortazavi
Seyyed Pejman Mortazavi
مجله سم شناسی و مسمومیتهای ایران Iranian Journal of Toxicology

1 September 2019 in Gene Reports
Verified
Journal Article
Closed access
RMRoya Mousazadeh
Roya Mousazadeh
SHSaeed Hesaraki
Saeed Hesaraki
MBMansour Bayat
Mansour Bayat
AJAlireza Jahandideh
Alireza Jahandideh
JHJamal Hashemi
Jamal Hashemi

Verified
Open access
PDF file
SHSaeed Hesaraki
Saeed Hesaraki
GAGh. Abedi
Gh. Abedi
SRS. Rismanchi
S. Rismanchi
This is a report of a penile fibrosarcoma in a two-year-old crossbred Holstein bull. The ulcerated tumormass with dimensions of 7 × 9 × 6.5 cm, was enveloped the glans and body of the penis. It had a white-graycolor at cross section appearance. There was no metastatic evidence of regional lymph node enlargement.Histopathologically, elongated spindle-shaped cells arranged densely in the interwoven pattern had a low rateof mitosis with oddly-shaped nuclei and pleomorphism. Immunohistochemically, the neoplastic cells werepositive for vimentin and S100, but negative for α-smooth muscle actin, desmin, C-KIT and GFAP.

1 July 2021 in Iraqi Journal of Veterinary Sciences
Verified
Journal Article
Open access
PDF file
SSShadman Shahzamani
Shadman Shahzamani
AJAlireza Jahandideh
Alireza Jahandideh
GAGholamreza Abedi
Gholamreza Abedi
AAAbolfazl Akbarzadeh
Abolfazl Akbarzadeh
SHSaeed Hesaraki
Saeed Hesaraki
PPPouya Parsaei
Pouya Parsaei
Abdominal adhesion is one of the main and important post-surgical problems and, according to available literature, the probability of their occurrence after surgery is higher than 50%. The present study intended to estimate the effect of Nano n-acetylcysteine on macroscopic and microscopic features post-surgical adhesions in an animal model. Twenty-five adult male Wistar rats, 200-220 gr, were randomly divided into five equal groups and underwent intramuscular anesthesia by injection of ketamine 10% at 50 mg/kg and injection of xylazine 2% at 5 mg/ kg. The treatments included three Nano-NAC groups at different dosages 50, 75 and 150 mg/kg, an NAC group, and a control group. On days 14 and 28 post-surgery, the abdomens of all rats were re-opened for macroscopic and microscopic evaluation of adhesions. Based on the results of macroscopic evaluation, the group receiving Nano-NAC 50 mg/kg had the lowest and the control group the highest mean adhesion scores on days14 and 28 post-operations. Histopathological evaluation also revealed that the group treated with Nano-NAC 50 mg/kg had the lowest level of inflammation and fibrosis score among the five groups on days 14 and 28 post-operation. Considering the results obtained in our experimental model and the increasing use of nanotechnology in the manufacture of biomedical drugs, it seems that use of Nano-NAC at low doses 50 and 75mg/kg after laparotomy can significantly reduce adhesions.